Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

被引:224
|
作者
Osoba, D
Beziak, A
Brundage, M
Zee, B
Tu, DS
Pater, J
机构
[1] QOL Consulting, W Vancouver, BC V7W 3H7, Canada
[2] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[3] Queens Univ, CTG, NCIC, Kingston, ON, Canada
[4] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China
关键词
health-related quality of life; analysis; interpretation; clinical trials;
D O I
10.1016/j.ejca.2004.10.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clinicians are being confronted with increasing amounts of health-related quality of life (HRQOL) data. Thus, there is a need for a greater understanding of the analysis and interpretation of HRQOL so that the data can be reported in an appropriate manner. The approach of the Clinical Trials Group of the National Cancer Institute of Canada emphasises the clinical meaning of the results, while avoiding complex statistical modelling. It consists of four steps: calculating the questionnaire completion rates, calculating the baseline scores, determining the individual change in scores over time for the domains specified in the trial hypothesis, and culminates in determining the proportions of patients who have reported clinically meaningful changes in scores since baseline. A rationale supporting each step is given. This approach is presented as a simple and practical aid to the analysis, interpretation and reporting of HRQOL results. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:280 / 287
页数:8
相关论文
共 50 条
  • [41] Clinical trials referral resource - Investigator-initiated health-related quality-of-life research
    Rowland, JH
    Varricchio, CG
    Trimble, EL
    Gore-Langton, RE
    ONCOLOGY-NEW YORK, 2001, 15 (10): : 1284 - +
  • [42] A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials
    Clayson, Darren J.
    Wild, Diane J.
    Quarterman, Paul
    Duprat-Lomon, Isabelle
    Kubin, Maria
    Coons, Stephen Joel
    PHARMACOECONOMICS, 2006, 24 (08) : 751 - 765
  • [43] Health-related quality-of-life (HRQoL) reporting by randomized cancer trials (RCT): Pitfalls for interpretation.
    Testa, L.
    Barbosa, C. C.
    Chaves, A. C.
    Hoff, P. M.
    Riechelmann, R. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] Health-related quality of life in phase III cancer clinical trials: From questionnaire administration to statistical analysis
    Fiteni, Frederic
    Anota, Amelie
    Westeel, Virginie
    Bonnetain, Franck
    BULLETIN DU CANCER, 2015, 102 (04) : 360 - 366
  • [45] Health-Related Quality of Life Data in Cancer Clinical Trials for Drug Registration: The Value Beyond Reimbursement
    Wasalski, Erinne
    Mehta, Shashi
    JCO CLINICAL CANCER INFORMATICS, 2021, 5 : 112 - 124
  • [46] Health related quality of life outcomes in cancer clinical trials
    Bottomley, A
    Flechtner, H
    Efficace, F
    Vanvoorden, V
    Coens, C
    Therasse, P
    Velikova, G
    Blazeby, J
    Greimel , E
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (12) : 1697 - 1709
  • [47] Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials
    St Germain, Diane
    Denicoff, Andrea
    Torres, Andrea
    Kelaghan, Joseph
    McCaskill-Stevens, Worta
    Mishkin, Grace
    O'Mara, Ann
    Minasian, Lori M.
    CANCER, 2020, 126 (11) : 2687 - 2693
  • [48] Assessment of health related quality of life in cancer clinical trials
    Kaasa, SK
    Loge, JHL
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 43 - 44
  • [49] International perspective on health-related quality-of-life research in cancer clinical trials: The European Organisation for Research and Treatment of Cancer Experience
    Bottomley, Andrew
    Aaronson, Neil K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (32) : 5082 - 5086
  • [50] Measuring health-related quality of life in clinical trials in cystic fibrosis
    Abbott, J.
    Hart, A.
    Havermans, T.
    Matossian, A.
    Goldbeck, L.
    Barreto, C.
    Bergsten-Brucefors, A.
    Besier, T.
    Catastini, P.
    Lupi, F.
    Staab, D.
    JOURNAL OF CYSTIC FIBROSIS, 2011, 10 : S82 - S85